Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Equity: 2010-2024

Historic Return on Equity for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to -0.04%.

  • Ani Pharmaceuticals' Return on Equity rose 10.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.04% for FY2024, which is 8.00% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Return on Equity is -0.04%, which was down 198.66% from 0.04% recorded in FY2023.
  • Ani Pharmaceuticals' 5-year Return on Equity high stood at 0.04% for FY2023, and its period low was -0.17% during FY2020.
  • Moreover, its 3-year median value for Return on Equity was -0.04% (2024), whereas its average is -0.04%.
  • Per our database at Business Quant, Ani Pharmaceuticals' Return on Equity fell by 15bps in 2020 and then climbed by 16bps in 2023.
  • Ani Pharmaceuticals' Return on Equity (Yearly) stood at -0.17% in 2020, then rose by 3bps to -0.14% in 2021, then rose by 2bps to -0.12% in 2022, then rose by 16bps to 0.04% in 2023, then dropped by 8bps to -0.04% in 2024.